Indian scientists to start clinical trials of plant-based covid shots

The so-called N-terminal region of SARS-CoV-2 S-glycoprotein consists of a receptor-binding domain (RBD), and studies have shown that antibodies against this region can effectively block RBD ACE2 (host-receptor) interaction, according to scientists

from mint - Science https://ift.tt/3gxyKHt
https://ift.tt/eA8V8J